Search

everythinglearnresearchcommunity

for

Search:↓

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

The PDGF/PDGFR pathway is a potential drug target with mixed success in treating various diseases, including some cancers and fibrosis.

Regulatory measures are needed to ensure safe production and use of platelet concentrates in Brazil.

Biomedical innovations could extend human lifespan, but may impact pension systems.

The FDA approved the first gene therapy for a blood disorder after overcoming early challenges and demonstrating patient benefits.

Bioengineered microneedles and nanomedicine offer promising, precise treatments for tissue regeneration.

Drug repurposing offers promising strategies to improve tuberculosis treatment despite challenges.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

The lecture concluded that drugs for human enhancement are here to stay and called for their responsible development and fair access.

Standardizing PRP therapy practices and regulations in Europe is crucial for safe and effective treatment.

FDA-cleared devices often fail to produce high-quality platelet-rich plasma consistently.

New liposomal formulations may improve delivery of treatments to hair follicles, potentially helping with hair loss.

The new drug delivery systems made with surfactants and block polymers are stable and not toxic.

Nanotechnology is improving drug delivery and targeting, with promising applications in cancer treatment, gene therapy, and cosmetics, but challenges remain in ensuring precise delivery and safety.

New nanocarriers were developed for safer, targeted drug delivery and diagnostics, showing promise for future medical use.

The compounding pharmacy in Venâncio Aires generally follows good practices, with only the Paracetamol sample showing significant microbial growth.

Cubosomes improve drug delivery for skin and eye diseases by enhancing adhesion, retention, and release.

Biologic agents can be effective for rheumatic diseases but have risks like infections and require careful monitoring and patient information.

New nanocarriers improve drug delivery for disease treatment.

Bioactive compounds in neurocosmetics can improve skin health and emotional well-being.

Nanoparticulate systems improve drug delivery by controlling release, protecting drugs, changing absorption and distribution, and concentrating drugs in targeted areas.

Small extracellular vesicles from stem and immune cells show promise for treating various diseases but face challenges in clinical use.

Redefining drug dosages is crucial when repurposing them for new uses.

INTASYL is a promising, adaptable RNAi technology for treating skin cancers.

Smart nano-PROTACs improve cancer treatment by targeting proteins more precisely and reducing side effects.

High-content screening is useful for finding new treatments for rare diseases and has led to FDA-approved drugs.

PLGA-based microneedles are promising for safe and effective skin delivery of drugs and vaccines.

3D bioprinting holds promise for medicine but needs more research and clear regulations.

New nanocarriers improve skin drug delivery with low toxicity at certain concentrations.

Nanoliposomes effectively deliver hair-growth peptides into hair follicles.